| University East Rehabilitation Center | |
| 991 E New York Ave, Deland, Florida 32724 | |
| (386) 734-9083 | |
| Name | University East Rehabilitation Center |
|---|---|
| Location | 991 E New York Ave, Deland, Florida |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 60 |
| Occupancy Rate | 61.83% |
| Medicare ID (CCN) | 105262 |
| Legal Business Name | University Center East Operating Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1194232066 |
| Organization Name | UNIVERSITY CENTER EAST OPERATING LLC |
| Doing Business As | UNIVERSITY EAST REHABILITATION CENTER |
| Address | 991 E New York Ave, Deland, FL 32724 |
| Phone Number | 386-734-9083 |
News Archive
Sen. Max Baucus is addressing the final questions in his Senate Finance Committee health care reform bill and plans to offer it Wednesday, opening the way for a committee vote next week and a floor vote the week after.
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
Soldiers in the National Guard with no history of alcohol abuse are at significant risk of developing alcohol-related problems during and after deployment, according to a new study published in Drug and Alcohol Dependence journal.
The nation's top public health official on Tuesday sharply criticized the widespread treatment of aches and pains with narcotics, saying that doctors are prescribing such drugs too soon, too often and for too long - putting patients at risk of addiction and overdose. Dr. Tom Frieden, director of the U.S. Centers for Disease Control and Prevention, said that doctors are relying on these powerful drugs to treat chronic pain when physical therapy, exercise and other remedies would be safer and in many cases more effective (Girion and Glover, 7/2).
› Verified 3 days ago
| NPI Number | 1346244191 |
| Organization Name | UNIVERSITY EAST REHABILITATION CENTER, LLC |
| Doing Business As | UNIVERSITY CENTER EAST |
| Address | 991 E New York Ave, Deland, FL 32724 |
| Phone Number | 386-734-9083 |
News Archive
Sen. Max Baucus is addressing the final questions in his Senate Finance Committee health care reform bill and plans to offer it Wednesday, opening the way for a committee vote next week and a floor vote the week after.
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
Soldiers in the National Guard with no history of alcohol abuse are at significant risk of developing alcohol-related problems during and after deployment, according to a new study published in Drug and Alcohol Dependence journal.
The nation's top public health official on Tuesday sharply criticized the widespread treatment of aches and pains with narcotics, saying that doctors are prescribing such drugs too soon, too often and for too long - putting patients at risk of addiction and overdose. Dr. Tom Frieden, director of the U.S. Centers for Disease Control and Prevention, said that doctors are relying on these powerful drugs to treat chronic pain when physical therapy, exercise and other remedies would be safer and in many cases more effective (Girion and Glover, 7/2).
› Verified 3 days ago
| NPI Number | 1710613500 |
| Organization Name | BLUE LAKE POST ACUTE LLC |
| Address | 991 E New York Ave, Deland, FL 32724 |
| Phone Number | 386-734-9083 |
News Archive
Sen. Max Baucus is addressing the final questions in his Senate Finance Committee health care reform bill and plans to offer it Wednesday, opening the way for a committee vote next week and a floor vote the week after.
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
Soldiers in the National Guard with no history of alcohol abuse are at significant risk of developing alcohol-related problems during and after deployment, according to a new study published in Drug and Alcohol Dependence journal.
The nation's top public health official on Tuesday sharply criticized the widespread treatment of aches and pains with narcotics, saying that doctors are prescribing such drugs too soon, too often and for too long - putting patients at risk of addiction and overdose. Dr. Tom Frieden, director of the U.S. Centers for Disease Control and Prevention, said that doctors are relying on these powerful drugs to treat chronic pain when physical therapy, exercise and other remedies would be safer and in many cases more effective (Girion and Glover, 7/2).
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Sen. Max Baucus is addressing the final questions in his Senate Finance Committee health care reform bill and plans to offer it Wednesday, opening the way for a committee vote next week and a floor vote the week after.
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
Soldiers in the National Guard with no history of alcohol abuse are at significant risk of developing alcohol-related problems during and after deployment, according to a new study published in Drug and Alcohol Dependence journal.
The nation's top public health official on Tuesday sharply criticized the widespread treatment of aches and pains with narcotics, saying that doctors are prescribing such drugs too soon, too often and for too long - putting patients at risk of addiction and overdose. Dr. Tom Frieden, director of the U.S. Centers for Disease Control and Prevention, said that doctors are relying on these powerful drugs to treat chronic pain when physical therapy, exercise and other remedies would be safer and in many cases more effective (Girion and Glover, 7/2).
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $136954 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 22.92 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.33 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 40 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.62 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 8.11 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.58 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 73.68 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 28.23 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 16.67 | 83.88 |